FDA Recall Open, Classified

Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing), CE marked

Recall: Z-0945-2022 · Initiated January 9, 2022

Recall

Recall Number
Z-0945-2022
Event Number
89755
Firm
Acon Biotech (Hangzhou) Co., Ltd.
FEI Number
3002829675
Product Code
QKP
Status
Open, Classified
Root Cause
No Marketing Application
Initiated
January 9, 2022
Address
398 Tianmushan Road, Hangzhou, China

Description

Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing), CE marked

Reason

Non-EUA authorized, CE marked, SARS-CoV-2 antigen rapid test kits are being recalled from the U.S. market because use may lead to inaccurate test results, including false negative or false positive test results.

Action

On 04/04/22, recall notices were sent to distributor customers who were asked to do the following: If you may have further distributed this product, please identify your customers and notify them at once of this product correction. Your notification to your customers may be enhanced by including a copy of this correction notification letter. This correction should be carried out to the consumer/user level in U.S. Complete and return the response form to the recalling firm. Customers with additional questions were encouraged to contact Denice Dong, [email protected] Additional instructions in a press release were provided to address affected non-EUA devices, of unknown quantity, that may have entered the U.S. market. It is recommended to stop use and dispose of affected devices in the U.S. market: https://www.aconlabs.com/news/

Distribution

US: MD, PA International Distribution to countries of: Hungary and China.

Quantity

303,760